AGNC Investment Corp. Dep. Pfd. (Rep. 6.875% Cum. Redeem. Pfd. Series D-0.20% AGNC Investment Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Series C)-0.19% AGNC Investment Corp ...
Rock Springs Capital, Logos Capital, Woodline, and Acuta Capital, amongst others. The cash will be used for further clinical development of Enliven’s two lead candidates, BCR-ABL inhibitor ELVN ...
AGNC Investment Corp. Dep. Pfd. (Rep. 6.875% Cum. Redeem. Pfd. Series D 0.20% AGNC Investment Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Series C)-0.08% AGNC Investment Corp ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results